Pharma News

pharma courses

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • Karnataka pharmacy council dissolved over irregularities
    9 April 2025

    Karnataka pharmacy council dissolved over irregularities

    The Karnataka state government has terminated the Karnataka State Pharmacy Council (KSPC) and entrusted an administrator with its responsibilities. The decision was taken after several complaints and a detailed government inquiry exposed serious irregularities, misuse of power, and failure to conduct timely elections.
  • 8 April 2025
    New study investigates effects of ADHD medications on the heart
    A new study led by the University of Southampton has found that medications for ADHD have overall small effects on blood pressure and heart rate after weeks or a few months of use. There have been concerns about the side effects of ADHD medications but the new findings, coupled with other studies, suggest that the benefits of taking these medications outweigh the risks, while highlighting the need for careful monitoring.
  • 8 April 2025
    Researchers Discover Way to Predict Treatment Success for Parasitic Skin Disease
    Nearly one million people worldwide are plagued annually by cutaneous leishmaniasis, a devastating skin infection caused by the Leishmania parasite. Predominantly affecting vulnerable populations in tropical and subtropical regions like North Africa and South America, this disease thrives in areas marked by malnutrition, poor housing and population displacement.
  • 8 April 2025
    Tulane researchers use AI to improve diagnosis of drug-resistant infections
    Drug-resistant infections especially from deadly bacteria like tuberculosis and staph are a growing global health crisis. These infections are harder to treat, often require more expensive or toxic medications and are responsible for longer hospital stays and higher mortality rates.
  • 7 April 2025
    Eplontersen approved in UK
    In people with this disease, small fibres of TTR protein clump together to make deposits called amyloid. Amyloid can build up around or within the nerves, heart and other organs, stopping them from working properly. Eplontersen is specifically indicated for use when the disease is causing polyneuropathy, which is damage to multiple nerves outside of the brain and central nervous system, resulting in pain, discomfort, progressive weakness and loss of sensation in the legs and arms, and mobility difficulties.
  • 7 April 2025
    Sun Pharma introduces a novel class of drug, Fexuclue (Fexuprazan) in India

    Sun Pharmaceutical Industries Limited announced that it has launched Fexuprazan tablets 40 mg in India under the brand name “FEXUCLUE® ”. FEXUCLUE® , a novel potassium- competitive acid blocker (PCAB), is approved as a new treatment for adults with Erosive Esophagitis of all grades.

  • 5 April 2025
    Lupin announces the Acquisition of Renascience in the United Kingdom
    Lupin Healthcare Limited, the wholly owned subsidiary of global pharma major Lupin Limited announced today the acquisition of Renascience Pharma Limited , a UK-based pharmaceutical company and sole supplier of 4 specialty products targeting unmet medical needs in the UK.
  • 5 April 2025
    A rice sized pacemaker that heals and dissolves, need no surgery

    Northwestern University engineers have developed a pacemaker so tiny that it can fit inside the tip of a syringe — and be non-invasively injected into the body.

    Although it can work with hearts of all sizes, the pacemaker is particularly well-suited to the tiny, fragile hearts of newborn babies with congenital heart defects.

  • 3 April 2025
    Organogold (III) complex accumulates in mitochondria of lung cancer cells

    Precious metals are not merely ornaments; they are also important components of pharmaceuticals, like the antitumor drug cisplatin. Recently, the search for alternatives with improved activity has begun to focus on gold. In the journal Angewandte Chemie, a French research team has now published the first study about the speciation and distribution of an organogold(III) complex in cancer cells and reveals how specially designed “organogold” complexes might open exciting avenues for fighting cancer. 

  • 3 April 2025
    KAIST Develops Retinal Therapy to Restore Lost Vision​

    Vision is one of the most crucial human senses, yet over 300 million people worldwide are at risk of vision loss due to various retinal diseases. While recent advancements in retinal disease treatments have successfully slowed disease progression, no effective therapy has been developed to restore already lost vision until now. KAIST researchers have successfully developed a novel drug to restore vision.

Subscribe to Pharma News